Articles related to Surgery, Colon & Rectal

A novel study has identified a distinct microbial fingerprint in patients with precancerous colon polyps, suggesting that the gut microbiome could play a pivotal role in early colorectal cancer detection.

Recent phase 2 trials have explored VX-548, a selective inhibitor of NaV1.8, in managing acute post-surgical pain. Dive deeper into the study’s findings and its implications for pain management.

This CME program hopes to enrich your understanding of IBD management, specifically focusing on biologic failure and surgical advancements.

Discover how an ER-to-OR pathway can effectively reduce inpatient admissions and lower treatment costs, particularly during times of healthcare system stress, in this detailed study analysis.

The evolving use of dopamine D2-receptor antagonists, marked by safety concerns and an FDA black box warning on droperidol, has seen a resurgence with the FDA-approved amisulpride, highlighting the need for further research to explore its comparison with other antiemetics and its role in multimodal PONV management.

A 51-year-old man presents with a 10-week history of intermittent bright red blood per rectum. His medical history is unremarkable, and he takes no medications. Physical examination reveals normal vital signs and a normal digital rectal examination. Fecal occult blood is positive. A colonoscopy identifies a nonobstructing lesion located 10 cm from the anal verge, while the rest of the colon appears normal. MRI scan results indicate that the lesion is invading into the muscularis but has not breached the full thickness, and there are no abnormal lymph nodes detected. Additionally, a contrast-enhanced CT scan of the chest and abdomen shows no signs of metastases. Biopsy results confirm the presence of adenocarcinoma. What is the most appropriate treatment for this patient?